The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy
用于预测接受一线曲妥珠单抗治疗的晚期 HER2 阳性食管胃腺癌患者生存期的 AGAMENON-SEOM 模型
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359231157641
Jimenez-Fonseca, Paula; Foy, Victoria; Raby, Sophie; Carmona-Bayonas, Alberto; Macía-Rivas, Lola; Arrazubi, Virginia; Cacho Lavin, Diego; Hernandez San Gil, Raquel; Custodio, Ana; Cano, Juana María; Fernández Montes, Ana; Mirallas, Oriol; Macias Declara, Ismael; Vidal Tocino, Rosario; Visa, Laura; Limón, María Luisa; Pimentel, Paola; Martínez Lago, Nieves; Sauri, Tamara; Martín Richard, Marta; Mangas, Monserrat; Gil Raga, Mireia; Calvo, Aitana; Reguera, Pablo; Granja, Mónica; Martín Carnicero, Alfonso; Hernández Pérez, Carolina; Cerdá, Paula; Gomez Gonzalez, Lucía; Garcia Navalon, Francisco; Pacheco Barcia, Vilma; Gutierrez Abad, David; Ruiz Martín, Maribel; Weaver, Jamie; Mansoor, Wasat; Gallego, Javier